|
 |
ImmunexThis page contains recent news articles, when available, and an overview of Immunex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Abbott Laboratories, Amgen, Baxter International, Ben Venue Laboratories, Boehringer Ingelheim Roxane, Immunex Corp. and Roxane Laboratories. Waterloo Cedar Falls Courier CellCyte Genetics Corp. Announces the Appointment of Douglas P. Cerretti, Ph.D ... - Nov 13, 2009 From 1984 to 2002 he served with Immunex and, after Immunex' acquisition in 2002, with Amgen in positions ranging from Staff Scientist through Scientific ... PharmaLive.com (press release) CellCyte Genetics Corp. Announces the Appointment of Douglas P. Cerretti, Ph.D ... - Nov 12, 2009 From 1984 to 2002 he served with Immunex and, after Immunex' acquisition in 2002, with Amgen in positions ranging from Staff Scientist through Scientific ... WELT ONLINE People in the News - Nov 13, 2009 ...the posts of CSO and director of business development. Cerretti has worked at Immunex, and has served as staff scientist and scientific director at Amgen. GenomeWeb Daily News O Biotech Brother, Where Art Thou? - Oct 21, 2009 Luke Timmerman of Xconomy.com caught a speech recently by Seattle biotech guru Christopher Henney, cofounder of Dendreon, Icos, and Immunex -- not too ... The IN VIVO Blog (blog) Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to ... - Oct 21, 2009 ...(e) To exclude the ongoing, non-cash amortization of acquired product technology rights, primarily ENBREL, related to the Immunex Corporation ("Immunex") ... Reuters 8 Red Flags of New Biotechs - Oct 22, 2009 Xconomy has a useful two-part interview with Christopher Henney, who helped to found Icos (ICOS), Dendreon (DNDN), and Immunex. ... Seeking Alpha (blog) Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring ... - Oct 21, 2009 ...vice president of basic research at Merck; Steve Gillis, the managing director of Arch Venture Partners who co-founded Immunex and Corixa; and Friend. ... Xconomy Triple DMARD Therapy Effective for Aggressive Treatment of Early Rheumatoid ... - Oct 21, 2009 Funding for this study was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, Immunex Corp., Barr Pharmaceuticals, ... DG News NPWZ Neah Power - Oct 27, 2009 The FTV partners have a combined 70 years of operating experience with industry leaders such as Microsoft, Visio, AT&T, Real Networks and Immunex. ... PR-Inside.com (Pressemitteilung) Soon-to-be-Joined Amgen and Immunex Miss Earnings Together - Dec 23, 2006 Amgen(AMGN Quote) and Immunex(IMNX Quote) are engaged, but the wedding is still a few months off, so Wednesday, each firm reported separate fourth-quarter ... TheStreet.com - TheStreet.com (subscription) Amgen Buys a Potential Blockbuster - Dec 16, 2005 What's more, it was through the Immunex deal that Amgen became Abgenix's partner. Back then, neither company really knew whether any of Abgenix's ... BusinessWeek State settles case against Amgen, Immunex - Dec 24, 2008 Wisconsin Attorney General JB Van Hollen has announced that the state has reached a $1.7 million agreement with phamaceutical manufacturers Amgen Inc., ... Bizjournals.com Biotech Behemoth - Jan 10, 2005 He spent $11 billion to acquire Immunex in 2002 (expanding Amgen into a third market, ... When the Seattle biotech shop Immunex stumbled in late 2001, ... Forbes Wyeth to join Trubion's work - Jan 4, 2006 Trubion Pharmaceuticals already had a lot in common with Immunex, the Seattle biotechnology ... Several of its executives worked at the former Immunex. ... Seattle Times Drug firm, MGH fight over royalties.(Massachusetts General Hospital ) - Jun 28, 2005 A major portion of its muscle stems from the $16 billion Immunex acquisition. ... The techniques Immunex used to create its decoys were first developed by ... Free with registration - Boston Globe - AccessMyLibrary.com Amgen to pay Mass. General $186m - Jun 6, 2006 Amgen later acquired Immunex and began reviewing its inherited licensing contracts. Royalty disputes like the Enbrel case are not unusual. ... Boston Globe Court rules for Amgen in Enbrel-related patent suit - Jan 29, 2007 The patent dispute, on the face of it, covers a protein used to treat rheumatoid arthritis that was originally licensed to Immunex Corp. before it was ... MarketWatch Amgen expanding its campus at Pier 89 - Mar 29, 2006 That would about meet the original Immunex plans. Fell said that is "welcome news" that could benefit "the entire biotech community in the Pacific Northwest ... Seattle Post-Intelligencer - Seattle Post Intelligencer Amgen seals deal to buy Abgenix for $2.2 billion - Dec 14, 2005 ...head and neck cancers the companies have been developing jointly since 2002 under an agreement Amgen assumed with its purchase of Immunex. ... USA Today Former Immunex Management Team Chosen to Head-Up CTI Subsidiary … - May 14, 2007 SEATTLE, May 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq; MTAX: CTIC) today announced the management team for its recently- formed ... Free with registration - PR Newswire - AccessMyLibrary.com Noted: Former Immunex CFO joins Omeros board - Aug 13, 2008 Seattle's Omeros Corp. said today it had appointed David Mann to its board. Mann was CFO at Seattle's Immunex from 1999 until it it was purchased by Amgen ... nwsource.com California; Amgen's Profit Surges 38% in Quarter; The biotech firm... - Jul 20, 2005 ...or 88 cents a share, if it had not incurred special charges related to its acquisition of rival Immunex Corp. and other one- time expenses. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Biotech veteran Henney gets key role in startup - Sep 20, 2007 Given Henney's record of creating valuable biotech companies -- Immunex was sold to Amgen for $11 billion in 2002 and Icos was sold to Eli Lilly for $2.1 ... Seattle Post-Intelligencer - Seattle Post Intelligencer Icos' gain is Seattle's loss - Oct 20, 2006 Many had the same feeling when Immunex -- one of the pioneers in Seattle's nascent ... Steven Gillis, who co-founded Immunex in 1981 and Corixa in 1994, ... Seattle Post-Intelligencer - Seattle Post Intelligencer Accelerator's fifth has California connection - Nov 4, 2005 Kenneth Grabstein, who worked at Seattle biotech stars Immunex Corp. and Corixa ... Grabstein spent 12 years at Immunex, which emerged as Seattle's leading ... Bizjournals.com ZymoGenetics' longtime CEO is stepping down - Nov 21, 2008 Williams was a top executive at Immunex, the Seattle biotech company that developed the blockbuster rheumatoid-arthritis drug Enbrel and was acquired by ... Seattle Times California and the West; Amgen's Earnings Rise 14% to $1 Billion - Apr 19, 2006 When Amgen announced the purchase of the Seattle-based biotechnology rival Immunex Corp. and its drug Enbrel in 2001 for about $17 billion, Chief Executive ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Alabama wins another $28M in drug firm settlements - Dec 23, 2008 The latest case included settlements with Bristol-Myers Squibb Co., KV Pharmaceuticals, Immunex Corp. and Bayer Pharmaceuticals. ... Bizjournals.com VLST Corporation and Accelerator Corporation Name Martin A. Simonetti... - Jan 6, 2006 Dr. Gillis, a biotech pioneer, co-founded both Immunex and Corixa and served ... Dr. Gillis also helped direct the development of Enbrel while at Immunex. ... RedOrbit Novo Nordisk opening Seattle site - Aug 6, 2008 I've been disappointed by how few people from Immunex, Icos started up companies. I think this is great news for this city." ... Seattle Post-Intelligencer - Seattle Post Intelligencer Biotech incubator launches new company Puget Sound Business Journal … - Jul 13, 2005 She also worked in management positions at Immunex Corp. and Amgen Inc., which acquired Immunex, and was a member of the team that discovered Enbrel, ... Bizjournals.com Amgen to boost business, add 150 jobs in Seattle - Jan 25, 2006 Immunex, acquired by Amgen in 2002, built the state's most successful ... As originally conceived by Immunex, the campus had a capacity of up to 2400 staff, ... Seattle Times Immunex Corporation - Company Snapshot - AlacraStore.com - Nov 5, 2008 Immunex Corporation Company Profile - View the latest news, market research, credit research, and investment research on Immunex Corporation. Pay-Per-View - co - Alacra Store Immunex obtains United States patent. - Mar 1, 2007 Immunex Corporation (Seattle, WA) has patented 4-1BB ligand (4-1BB-L) polypeptides and a human cell surface receptor designated 4-1BB that binds 4-1BB-L are ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com Seattle high-tech layoff tracker | Seattle Post-Intelligencer - Jul 19, 2005 Sources familiar with the exit of Steven Gillis, who also co-founded Immunex Corp., said they learned the news last week, when GlaxoSmithKline told Corixa ... Seattle Post-Intelligencer - Seattle Post Intelligencer Amgen slates major growth for Seattle research campus - Mar 28, 2006 The expansion fulfills larger plans that Immunex, the Seattle biotech company ... "There was a master plan for the campus that Immunex filed with the city," ... Seattle Times CLOSER LOOK RESEARCH FINDINGS - Jan 21, 2008 The trial was supported by Immunex, a wholly owned subsidiary of Amgen, and by Wyeth Pharmaceuticals. Amgen and Wyeth Pharmaceuticals, a division of Wyeth, ... $2.95 - Milwaukee Journal Sentinel - NewsBank Press Release: Former Immunex Management Team Chosen to Head-Up … - May 14, 2007 Former Immunex Management Team Chosen to Head-Up CTI Subsidiary Aequus BioPharma, Inc. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Amgen plans to expand its operation in Seattle - Jan 24, 2006 When originally conceived by Immunex, the Seattle company Amgen acquired in ... "This site is really focused on research and development whereas Immunex was ... Seattle Times Vulcan, Immunex veteran named CEO at Anesiva - Jun 16, 2008 Anesiva Inc., a South San Francisco biotech company, named Michael Kranda -- a veteran of both Vulcan and Immunex -- as its CEO today. ... nwsource.com Article: Immunex obtains United States patent. - BIOTECH Patent News... - Mar 1, 2007 Immunex obtains United States patent. ... find BIOTECH Patent News articles. Immunex Corporation (Seattle, WA) has patented 4-1BB ligand (4-1BB-L) ... Pay-Per-View - BIOTECH Patent News - HighBeam Research ZymoGenetics files lawsuit against Bristol-Myers Squibb - Aug 14, 2006 In Amgen's case, the deal was part of a settlement of ZymoGenetics' 2002 patent infringement lawsuit against Immunex, which Amgen acquired. ... Seattle Times AMGEN EARNINGS BEAT WALL STREET EXPECTATIONS - Jul 21, 2005 ...or 88 cents a share, if it had not incurred special charges related to the now-completed acquisition of rival Immunex and other one-time expenses. ... $2.95 - San Jose Mercury News - NewsBank Trubion announces plans for IPO - Jun 4, 2006 Several of Trubion's top staffers came from Immunex. The Seattle-based biotech says it is planning to hire about 27 new staffers by the end of this year. FierceBiotech VLST Corp. Adds Vice President, Senior Director - Sep 17, 2007 She has also held director-level positions at Immunex Corp. and NPS Pharmaceuticals Inc. Allison comes to VLST from ICOS Corp., where he most recently ... Northwest innovation Immunex and LJL Biosystems are Among Recent Patent Winners - Jan 11, 2005 Lam Nguyen, Miguel Bravo-Zanoquera, Albert Kellner, and Jeffrey Price have been awarded US Patent No. 6839469, “Multiparallel three-dimensional optical ... genomeweb.com Pittsburgh's Ohio Valley General Hospital to Dedicate Irene E.... - Apr 11, 2006 Ed Fritzky is the former CEO of Immunex, a Seattle-based biotechnology company that ... Fritzky's career then led him to Immunex, where he was charged with ... $4.95 - PR Newswire - ECNext Kansas AG sues 17 more drug companies over pricing - Nov 17, 2008 For example, Amgen/Immunex reported an AWP of $137.94 for their drug Leucovorin Calcium, yet they sold the same drug to retail pharmacists for $14.58-a ... Legal News Line … Court Opinions - POMPEY v. IMMUNEX CORPORATION (EDLa. 2005) - Jan 24, 2005 IMMUNEX CORPORATION (EDLa. 2005) VICTORIA POMPEY v. IMMUNEX CORPORATION ... Page 2 BACKGROUND On December 16, 2004, defendants, Immunex Corporation and ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Immunex obtains United States patent.(Brief Article) - Jan 1, 2005 Immunex Corporation (Seattle, WA), Max-Planck-Institute for Biochemistry (Klopferspitz, Germany), and Wyeth (Madison, NJ) have patented a tumor necrosis ... Free with registration - BIOTECH Patent News - AccessMyLibrary.com Trubion Hires Stromatt as Chief Medical Officer, Replacing Burge - Aug 18, 2008 Burge, 46, a veteran of Amgen and Immunex, joined Trubion in 2004. Luke Timmerman is the National Biotechnology Editor for Xconomy. ... Xconomy Amgen Inc intends a stock buyback - Deal Snapshot - AlacraStore.com - Jul 12, 2007 Amgen + Synergen Synergen Synergen Synergen Amgen Amgen + Immunex Amgen Immunex + Tularik Amgen Immunex Tularik…#### #### #### #### #### Amgen + Synergen ... Pay-Per-View - deals - Alacra Store San Diego Business Journal Online - business news for San Diego, … - Apr 4, 2008 Fisher has also served at Cephalon, Immunex and Boehringer Ingelheim. SkinMedica CEO Rex Bright will continue as president and member of the company's board ... San Diego Business Journal - San Diego Business Journal Amgen goal: to be good neighbor - May 12, 2005 Many respected Immunex scientists and managers left the company, ... Richard Gayle, a former Immunex scientist who now runs research at a startup called ... Seattle Times Iran mass produces interferon beta 1 - Apr 13, 2008 Gamma Immunex (recombinant interferon beta 1) is an effective treatment for patients suffering from infectious diseases such as chronic granulomatous and ... PRESS TV … Partners Names Steve Gillis, Co-Founder of Immunex and Corixa, as ... - Aug 2, 2005 ARCH Venture Partners Names Steve Gillis, Co-Founder of Immunex and Corixa, as Venture Partner. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Amgen announces licensing deal, earnings Los Angeles Business from … - Jan 26, 2006 The current quarterly earnings include a nine-cent-per-share charge related to the acquisitions of Immunex Corp. and Tularik Inc. ... Los Angeles Business Immunex obtains United States patent.(Brief Article) | Article from … - Jan 1, 2005 Immunex obtains United States patent.(Brief Article) ... find BIOTECH Patent News articles. Immunex Corporation (Seattle, WA), Max-Planck-Institute for ... Pay-Per-View - BIOTECH Patent News - HighBeam Research … Partners Names Steve Gillis, Co-Founder of Immunex and Corixa, as ... - Aug 2, 2005 2 /PRNewswire/ -- ARCH Venture Partners announced today that Dr. Steven Gillis, Ph.D., co-founder of Immunex and Corixa Corporations, has joined the firm as ... $4.95 - PR Newswire - ECNext Eli Lilly, Icos $2.1 billion deal likely means layoffs - Oct 17, 2006 ..."The loss of Immunex from the biotech investment community was profound ... Still, Immunex kept many of its employees in Seattle and continues to grow here. ... Seattle Post-Intelligencer - Seattle Post Intelligencer ARCH Adds Immunex Co-Founder Steven Gillis To Life Science Team - Aug 3, 2005 Gillis' involvement in biotech stems from his co-founding, in 1981, of Immunex Corp., where he eventually served as the chairman and CEO. ... Subscription - VentureWire Alert - Dow Jones Financial Information Services Los Angeles Business Journal Online - business news and information... - Apr 21, 2005 ...a year earlier if it had not incurred special charges related to its major acquisitions of Immunex Corp. and Tularik Inc. Revenue was not affected. ... Los Angeles Business Journal Schering adds DrKW for defence - Mar 16, 2006 DrKW was sole adviser to Schering on its $380m acquisition of a unit of US rival Immunex in 2002. Merck, advised by Bear Stearns, Deutsche Bank and Goldman ... Financial News - Financial News (subscription) Protein Design Labs Names Dr. Peter Calcott Vice President, Quality... - Sep 19, 2005 Prior to that, he held senior level quality positions with Immunex Corp., Bayer AG, SmithKline Beecham and Monsanto Company. A native of the United Kingdom, ... $4.95 - PR Newswire - ECNext Amgen Inc intends a stock buyback - Deal Snapshot - AlacraStore.com - Dec 13, 2006 Amgen + Synergen Synergen Synergen Synergen Amgen Amgen + Immunex Amgen Immunex + Tularik Amgen Immunex Tularik…#### #### #### #### #### Amgen + Synergen ... Pay-Per-View - deals - Alacra Store Amgen Inc buys back stock (pending) - Deal Snapshot - AlacraStore.com - Mar 1, 2006 Amgen + Synergen Synergen Synergen Synergen Amgen Amgen + Immunex Amgen Immunex + Tularik Amgen Immunex Tularik…#### #### #### #### #### Amgen + Synergen ... Pay-Per-View - deals - Alacra Store Amgen Inc intends a stock buyback - Deal Snapshot - AlacraStore.com - Dec 7, 2005 Amgen + Synergen Synergen Synergen Synergen Amgen Amgen + Immunex Amgen Immunex + Tularik Amgen Immunex Tularik…#### #### #### #### #### Amgen + Synergen ... Pay-Per-View - deals - Alacra Store United States Federal Circuit Court of Appeals Reports - ISRAEL BIO- … - Mar 15, 2005 The '701 patent was later licensed to Amgen, Inc. ("Amgen"), the Immunex Corporation ... In 1999, IBEP filed suit against Amgen, Immunex and Wyeth for ... Pay-Per-View - United States Federal Circuit Court of... - Loislaw Article: OF NOTE - The Washington Post | HighBeam Research - FREE … - Jan 30, 2007 Article: CYANAMID AND IMMUNEX FORM NEW BIOPHARMACEUTICAL ... ... Canada with Immunex to form a new biopharmaceutical company has been approved by Immunex ... Pay-Per-View - Washington Post - HighBeam Research Loislaw Federal District Court Opinions - HUMAN GENOME SCIENCES, … - Apr 8, 2008 ...fn9] Immunex was involved in the interference on the basis of U.S. Patent No. ... fn19] Immunex did not dispute HGS' claim to benefit for the purposes of ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Amgen CEO says hot drug Enbrel means more jobs ahead for Rhode … - Oct 17, 2005 Sharer was at the company's helm in 2002 when it purchased Immunex Corp. for ... At the time, Immunex was retrofitting an existing manufacturing facility in ... Free with registration - Providence Journal - AccessMyLibrary.com Press Release: Finalists for the Ernst & Young Entrepreneur Of The... - May 23, 2007 Hallquist, Immunex senior vice president and general counsel. Immunex . ... D., Immunex executive vice president and director of research and development. ... Pay-Per-View - PR Newswire - HighBeam Research MEDICAL EDGE ASK THE MAYO CLINIC.(Life and Arts) | Article from … - Feb 25, 2008 Article: IMMUNEX DRUG WINS EARLY OK FROM FDA MAY HELP MILLIONS WITH ... ... Article: IMMUNEX SAYS MONTHLY ENBREL SALES SURGE RHEUMATOID ... ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research La bioproduction, passage obligé pour la biotech française - Oct 16, 2008 Les déboires rencontrés en 2002 par Immunex (racheté depuis par Amgen) avec son produit Enbrel, une protéine dont la société américaine avait sous-traité ... Les Échos - Les Échos 盘å?Žï¼šGoogle业绩上佳股价大涨6% - Apr 22, 2005 ...è‹¥ä¸?计与收è´Tularik Inc.å’ŒImmunex Corp.相关的开支，Amgençš„æ¯?股净所得为72美分。 æ¤å‰?，分æž?师平å?‡é¢„期：Amgenæ¯?股将盈利68美分，è?¥æ”¶å°†è¾¾28亿7000万美元。 ... 新浪网 Insider tales from the biotech front - Sep 8, 2006 When Immunex won FDA approval for Leukine, a drug that prevents infection ... Neupogen held its 20-to-1 lead and Immunex found itself with enough Leukine to ... sptimes.com Amgen's sales elixir works magic in 2004, but slowdown may loom. - Jan 28, 2005 The company bought Immunex for $10 billion in 2002, then Tularik of South San ... At the time it acquired Immunex, Amgen said it anticipated $3 billion in ... Free with registration - Seattle Times - AccessMyLibrary.com BIOTECH GIANTS GETS BIGGER.(Business) | Article from Daily News ( … - Dec 15, 2005 After buying Immunex in 2002, Thousand Oaks-based Amgen began working closely with Abgenix on ... Article: AMGEN PRESSES AHEAD PURCHASE OF IMMUNEX AFFECTS . ... Pay-Per-View - Daily News - HighBeam Research Loislaw Federal District Court Opinions - HUMAN GENOME SCIENCES, … - Dec 17, 2008 10/005842 ("the `842 application") and defendant Immunex Corp.'s ("Immunex"'s) US Patent No. 6642358 ("the `358 patent"). Immunex was named the Senior Party ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Article: TIMELY DISCLOSURE CRITICAL IN DRUG TRIALS.(Editorial)( … - Sep 19, 2007 Article: IMMUNEX SHOOTS FOR THE TOP TIER ARTHRITIS DRUG GETS RESULTS IN . ... Immunex. The Immunex that is shepherding Enbrel through final clinical trials ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research Building factory a balancing act for Dendreon - Aug 9, 2006 Urdal said the company is being careful not to repeat mistakes like ones he saw earlier in his career at Seattle-based Immunex. He was there in the early ... Seattle Times Article: Amgen will lease GTECH's West Greenwich headquarters. - … - Jun 1, 2006 Article: Purchase of Immunex Shouldn't Affect Jobs at West ... ... Article: Immunex Pushes Back Opening of Its West Greenwich, ... ... Pay-Per-View - Providence Journal - HighBeam Research Drug rep's suit alleges unethical marketing plan | Article from The... - Nov 28, 2007 The trouble started in 2002 after Amgen acquired Immunex Corp., ... The deal depends on the completion of the Amgen-Immunex merger and would be voided if . ... Pay-Per-View - The Record - HighBeam Research Dynavax Appoints Peggy V. Phillips to Board of Directors. - Aug 16, 2006 Under her direction, Immunex developed, registered and launched Enbrel(R). Enbrel became a leading product for the treatment of immune system disorders. ... Free with registration - PR Newswire - AccessMyLibrary.com Scientist shares very personal reason her lifetime ambition sustains... - Mar 17, 2006 When Amgen bought Immunex in 2002, McCoy took a year off before joining Berlex, the US affiliate of Schering AG, a giant German pharmaceutical company. ... Puget Sound Business Journal Surface Logix Appoints Steven Gillis, Ph.D. to Board Of Directors. - Jan 25, 2006 Dr. Gillis was also a founder and director of Immunex Corporation. ... Dr. Gillis was interim Chief Executive Officer of Immunex following its majority ... Free with registration - PR Newswire - AccessMyLibrary.com Article: Drug companies pay sanctioned doctors; FDA should keep... - Jun 5, 2007 Drug Week; May 18, 2001 ; 700+ words ...2001 MAY 18 - (NewsRx Network) -- Abgenix, Inc. (ABGX) and Immunex Corp. (IMNX) announced April 18, 2001, ... Pay-Per-View - Star Tribune - HighBeam Research Amgen near accord with hospital over drug royalty. - Mar 3, 2006 Amgen inherited the royalty arrangement in 2001 when it bought Immunex Corp., ... Amgen's lawyers reviewed the contract Immunex negotiated with the hospital ... Free with registration - Boston Globe - AccessMyLibrary.com Press Release: Dynavax Appoints Peggy V. Phillips to Board of... - Aug 16, 2006 Under her direction, Immunex developed, registered and launched Enbrel(R). Enbrel became a leading product for the treatment of immune system disorders. ... Pay-Per-View - PR Newswire - HighBeam Research Loislaw Federal District Court Opinions - HUMAN GENOME SCIENCES, … - May 9, 2008 AMGEN, INC. and IMMUNEX CORP., Defendants. Civ. No. 07-780-SLR. ... (Id. at ¶ 13) Defendant Immunex was declared the Senior Party and was presumed to be the ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Press Release: Paradigm Therapeutics Ltd Acquires Amedis … - Jan 7, 2005 S Genmab A/S is a biotechnology company that creates and develops fully human ... conducted at leading international companies, including Roche, Immunex ... Pay-Per-View - PR Newswire - HighBeam Research Trubion Appoints Dr. Steven Gillis to Board of Directors. - Feb 8, 2006 Dr. Gillis is also a founder of Immunex Corporation. ... Dr. Gillis was interim chief executive officer of Immunex following its majority purchase by ... $4.95 - PR Newswire - ECNext Biotech failure all too familiar. - Apr 6, 2005 At Immunex, he said, management's attitude was, "We tried something, ... Immunex researchers had to refocus after its drug Enbrel failed in its first big ... Free with registration - Seattle Times - AccessMyLibrary.com Accelerator adds high-profile execs at Spaltudaq - Aug 18, 2006 Gillis, a founder of Corixa and another well-known Seattle biotech, Immunex Corp., occupies the chairman seat at VLST Corp. as well. ... Bizjournals.com Biotech maximizes assets with sales team - Mar 3, 2008 The region has produced only two big sellers: rheumathoid-arthritis drug Enbrel, developed at Immunex; and erectile-dysfunction treatment Cialis, by Icos. ... Seattle Times INVESTORS HAVE NO SAY OVER EXEC PAY.(Editorial) | Article from … - Mar 25, 2007 About 500 Immunex shareholders gathered at yesterday's ... Richard Hunt, an Immunex shareholder, who has owned stock since ... performance over the years. ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research READ THIS.(Life and Arts) | Article from Seattle Post-Intelligencer... - Jun 20, 2007 Article: IMMUNEX ACTS TO INCREASE ENBREL OUTPUT 2ND RHODE ... ... Article: IMMUNEX BEGINS WORK ON NEW PLANT ENBREL DEMAND SPURS BIG PROJECT ... ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research THERE'S SOMETHING ABOUT RICHARD JENKINS 'WHAT'S HIS NAME' … - Apr 17, 2008 Article: IMMUNEX ACTS TO INCREASE ENBREL OUTPUT 2ND RHODE ... ... Article: IMMUNEX BEGINS WORK ON NEW PLANT ENBREL DEMAND SPURS BIG PROJECT ... ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research CAMPAIGN COUNTDOWN: 246 DAYS TO GO.(News) | Article from … - Mar 4, 2008 Article: IMMUNEX ACTS TO INCREASE ENBREL OUTPUT 2ND RHODE ... ... Article: IMMUNEX BEGINS WORK ON NEW PLANT ENBREL DEMAND SPURS BIG PROJECT ... ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research BOOKS.(Life and Arts) | Article from Seattle Post-Intelligencer... - May 14, 2008 Article: IMMUNEX ACTS TO INCREASE ENBREL OUTPUT 2ND RHODE ... ... Article: IMMUNEX BEGINS WORK ON NEW PLANT ENBREL DEMAND SPURS BIG PROJECT ... ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research Article: CAMPAIGN COUNTDOWN: 245 DAYS TO GO <TEXT> </TEXT></ … - Mar 5, 2008 Article: IMMUNEX ACTS TO INCREASE ENBREL OUTPUT 2ND RHODE ... ... Article: IMMUNEX BEGINS WORK ON NEW PLANT ENBREL DEMAND SPURS BIG PROJECT ... ... Pay-Per-View - Seattle Post-Intelligencer - HighBeam Research Amgen yanks ad for Enbrel. | Article from Providence Journal (Providen... - Feb 22, 2005 Article: Purchase of Immunex Shouldn't Affect Jobs at West Greenwich, ... ... In taking over Immunex, Amgen acquired a rheumatoid arthritis drug, Enbrel, ... Pay-Per-View - Providence Journal - HighBeam Research Amgen gets OK to make Enbrel. | Article from Providence Journal ( … - Sep 2, 2005 Article: Purchase of Immunex Shouldn't Affect Jobs at West ... ... Research's share of the West Greenwich facility. Immunex ... ... Pay-Per-View - Providence Journal - HighBeam Research Lottery giant plans Route 95 office park. | Article from Providence... - Mar 16, 2006 Research's share of the West Greenwich facility. Immunex ... ... Article: Purchase of Immunex Shouldn't Affect Jobs at West ... ... Pay-Per-View - Providence Journal - HighBeam Research "Significant" job cuts will follow sale of Icos, region's biggest... - Oct 17, 2006 The region's pioneering biotech company, Immunex, developed a successful rheumatoid ... Since the takeover of Immunex, other companies with big ambitions ... Pay-Per-View - Seattle Times - HighBeam Research Amgen Overload 2007 was anot ... | Article from The Washington Post |... - Apr 15, 2008 Article: Amgen Agrees to Buy Immunex in Record Biotech Deal ... Article: In Immunex, Amgen Sees a Prize; Biotech Firms Talk Merger, ... ... Pay-Per-View - Washington Post - HighBeam Research Press Release: Too Many Companies With Biogeneric G-CSF Products … - Oct 17, 2005 Article: Immunex fuses GM-CSF and IL-3 in hybrid molecule; studies ... ... Immunex Corporation's GM-CSF (granulocyte-macrophage colony stimulating ... Pay-Per-View - PR Newswire - HighBeam Research ONE IDEA.(Business) | Article from Daily News (Los Angeles, CA) | … - Mar 6, 2005 Article: AMGEN PRESSES AHEAD PURCHASE OF IMMUNEX AFFECTS ... Daily News (Los Angeles, CA); ... Article: AMGEN DEAL GAINS OK SHAREHOLDERS APPROVE IMMUNEX ... ... Pay-Per-View - Daily News - HighBeam Research Press Release: H. Stewart Parker Joins Board of Directors of Neose … - May 3, 2005 She served in various capacities at Immunex from August 1981 through December 1991, most recently as vice president, corporate development. ... Pay-Per-View - PR Newswire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |